Oncolytic vaccinia therapy of squamous cell carcinoma

BACKGROUND: Novel therapies are necessary to improve outcomes for patients with squamous cell carcinomas (SCC) of the head and neck. Historically, vaccinia virus was administered widely to humans as a vaccine and led to the eradication of smallpox. We examined the therapeutic effects of an attenuate...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Zhenkun, Li, Sen, Brader, Peter, Chen, Nanhai, Yu, Yong A, Zhang, Qian, Szalay, Aladar A, Fong, Yuman, Wong, Richard J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714037/
https://www.ncbi.nlm.nih.gov/pubmed/19580655
http://dx.doi.org/10.1186/1476-4598-8-45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714037/
https://www.ncbi.nlm.nih.gov/pubmed/19580655
http://dx.doi.org/10.1186/1476-4598-8-45

Ejemplares similares